Treating the obese dialysis patient: challenges and paradoxes.

abstract：:United States standards for the microbiologic quality of dialysate are not very stringent and have remained unchanged for more than 20 years, despite significant changes in the patient population and in the technology of hemodialysis. Numerous studies have demonstrated that bacterial products can cross dialysis membra...

journal_title：Seminars in dialysis

authors： Ward RA

更新日期：2000-11-01 00:00:00

abstract：:The in-center dialysis unit and practice of dialysis, in the current multi-team approach, requires knowledge and skills in all the domains including medical expert, communicator, collaborator, scholar, health advocate, and leader. We are tasked as a community, to embrace and incentivize new innovations and technology ...

journal_title：Seminars in dialysis

authors： Moist LM,Lindsay RM

更新日期：2018-03-01 00:00:00

abstract：:Presternally exiting peritoneal dialysis (PD) catheters have been described as advantageous compared to abdominally exiting catheters with regard to infection, wound healing, and other complications. Placement of such catheters has only been described with open surgical techniques and not by percutaneous means. In thi...

journal_title：Seminars in dialysis

authors： Sreenarasimhaiah VP,Margassery SK,Martin KJ,Bander SJ

更新日期：2004-09-01 00:00:00

abstract：:Hyperhomocysteinemia is an independent cardiovascular risk factor, according to most observational studies and to studies using the Mendelian randomization approach, utilizing the common polymorphism C677T of methylene tetrahydrofolate reductase. In contrast, the most recent secondary preventive intervention studies, ...

journal_title：Seminars in dialysis

authors： Perna AF,Ingrosso D,Violetti E,Luciano MG,Sepe I,Lanza D,Capasso R,Ascione E,Raiola I,Lombardi C,Stenvinkel P,Massy Z,De Santo NG

更新日期：2009-07-01 00:00:00

abstract：:Parenteral iron is used to restore the body's iron pool before and during erythropoiesis-stimulating agent (ESA) therapy; together these agents form the backbone of anemia management in end-stage renal disease (ESRD) patients undergoing hemodialysis. ESRD patients receiving chronic intravenous iron products, which exc...

journal_title：Seminars in dialysis

authors： Rostoker G

更新日期：2019-01-01 00:00:00

abstract：:Dialysate leakage represents a major noninfectious complication of peritoneal dialysis (PD). An exit-site leak refers to the appearance of any moisture around the PD catheter identified as dialysate; however, the spectrum of dialysate leaks also includes any dialysate loss from the peritoneal cavity other than via the...

journal_title：Seminars in dialysis

authors： Leblanc M,Ouimet D,Pichette V

更新日期：2001-01-01 00:00:00

abstract：:There is clear evidence that survival rates following transplantation far exceed those for remaining on dialysis, regardless of body size measured by body mass index (BMI). Studies over the past 15 years also suggest little to no difference in long-term outcomes, including graft survival and mortality, irrespective of...

journal_title：Seminars in dialysis

authors： MacLaughlin HL,Campbell KL

更新日期：2019-05-01 00:00:00

abstract：:The 180 l of glomerular filtrate formed each day contain some 1100 g (2.5 pounds) of sodium chloride, of which only 5-10 g are excreted in the urine--95% is reabsorbed by the tubules. Some 425 g (nearly a pound) of sodium bicarbonate and 145 g of glucose are filtered, and more than 99% of both are reabsorbed. Also fil...

journal_title：Seminars in dialysis

authors： Weisberg LS,Zanger R

更新日期：2010-11-01 00:00:00

abstract：:Cardiovascular complications are the leading cause of mortality in patients with end-stage renal disease (ESRD). The excess cardiovascular risk and mortality is already demonstrable in early renal disease and in patients with chronic renal failure (CRF), with the highest relative risk of mortality in the youngest pati...

journal_title：Seminars in dialysis

authors： London GM

更新日期：2003-03-01 00:00:00

abstract：:Secondary hyperparathyroidism almost universally accompanies end-stage renal disease (ESRD). In some, but not all studies, elevated serum parathyroid hormone (PTH) concentrations are associated with increased fracture rates, cardiovascular disease, and mortality in ESRD. The serum concentration of PTH required for opt...

journal_title：Seminars in dialysis

authors： Zand L,Kumar R

更新日期：2016-05-01 00:00:00

abstract：:The treatment of end-stage renal disease (ESRD) makes extensive use of presterilized disposable items which, after use, are contaminated by blood. The preferred route of disposal of such items is by incineration. Disposal costs have risen and this increase in costs has not been matched by waste management programs in ...

journal_title：Seminars in dialysis

authors： Hoenich NA,Levin R,Pearce C

更新日期：2005-09-01 00:00:00

abstract：:Despite decades of research, there are few published guidelines related to the safety and efficacy of exercise training in hemodialysis patients. This has led to disparate recommendations regarding the type, intensity, and timing for exercise, especially for patients with multiple comorbidities. Many common recommenda...

journal_title：Seminars in dialysis

authors： Wilund KR,Jeong JH,Greenwood SA

更新日期：2019-07-01 00:00:00

abstract：:Parathyroidectomy (PTX) remains an important intervention for dialysis patients with poorly controlled secondary hyperparathyroidism (SHPT), though there are only retrospective and observational data that show a mortality benefit to this procedure. Potential consequences that we seek to avoid after PTX include persist...

journal_title：Seminars in dialysis

authors： Kakani E,Sloan D,Sawaya BP,El-Husseini A,Malluche HH,Rao M

更新日期：2019-11-01 00:00:00

abstract：:The patency of the vascular access (VA) is a fight for the attending nephrologist. A retrospective observational study was conducted to compare the success rate of surgical versus endovascular technique percutaneous transluminal angioplasty (PTA) for graft thrombosis treatment. Of 3008 patients, 22.1% patients were di...

journal_title：Seminars in dialysis

authors： Ponce P,Carvalho T,Messias H,Neves F,Lisbon VAC Interventional Nephrology Team.

更新日期：2014-09-01 00:00:00

abstract：:The bone disease associated with end-stage renal failure (ESRD) and treatment are complex and multifactorial, and has changed in both clinical and imaging features over the past three decades. Whereas previously features of vitamin D deficiency (rickets/osteomalacia) and intense, and prolonged, secondary hyperparathyr...

journal_title：Seminars in dialysis

authors： Adams JE

更新日期：2002-07-01 00:00:00

abstract：:Several neurologic disorders have been treated with therapeutic plasma exchange (TPE). Case reports, case series, and clinical trials have published results regarding the outcomes in such patients. The data gathered have been used to formulate evidence-based guidelines, which can be used to guide therapy in patients w...

journal_title：Seminars in dialysis

authors： Chhibber V,Weinstein R

更新日期：2012-03-01 00:00:00

abstract：:While oral diuretics are commonly used in patients with chronic kidney disease for the management of volume and blood pressure, they are often discontinued upon initiation of dialysis. We suggest that diuretics are considerably underutilized in peritoneal dialysis and haemodialysis patients despite numerous potential ...

journal_title：Seminars in dialysis

authors： Trinh E,Bargman JM

更新日期：2016-09-01 00:00:00

abstract：:Dialysis vascular access associated coronary-subclavian steal or hypoperfusion syndrome is an uncommon but potentially life threatening condition. Awareness of this syndrome is important in the management of vascular access in hemodialysis patients. We report a case of dialysis vascular access associated coronary-subc...

journal_title：Seminars in dialysis

authors： Tan CS,Fintelmann F,Joe J,Ganguli S,Wu S

更新日期：2013-09-01 00:00:00

abstract：:Data derived from a large cohort of hemodialysis patients (12,896) undergoing dialysis access maintenance procedures being performed by interventional nephrologists were analyzed to determine the safety of sedation/analgesia (S/A) in a freestanding facility. Data collected included patient demographics, procedures per...

journal_title：Seminars in dialysis

authors： Beathard GA,Urbanes A,Litchfield T,Weinstein A

更新日期：2011-01-01 00:00:00

abstract：:Although many nephrologists see value in maximizing clearance and time on dialysis, clinical trials have failed to show a clear and consistent benefit of increasing clearance above the minimum threshold level recommended in clinical practice guidelines or of increasing dialysis session length or frequency. Available e...

journal_title：Seminars in dialysis

authors： O'Hare AM

更新日期：2020-11-01 00:00:00

abstract：:Despite improvements in the delivery of care, the annual all-cause mortality rate for end-stage renal disease (ESRD) patients is still around 220 deaths per 1000 at risk patient-years. Infection-related causes are second only to cardiovascular events as a cause for mortality among ESRD patients. Almost two-thirds of a...

journal_title：Seminars in dialysis

authors： Camins BC

更新日期：2013-07-01 00:00:00

abstract：:Mounting evidence supports a strong association between fluid management and outcomes among individuals receiving maintenance hemodialysis. The speed of fluid removal during dialysis (ultrafiltration, UF) is a modifiable aspect of fluid management that has attracted recent attention as a potential performance measure ...

journal_title：Seminars in dialysis

authors： Flythe JE

更新日期：2016-11-01 00:00:00

abstract：:Measurement of small molecule clearance remains important in the clinical care of patients requiring long-term dialysis. Many patients maintain a significant degree of residual native kidney function and may have nontraditional schedules with or without combined dialysis modalities. In this review, we examine and outl...

journal_title：Seminars in dialysis

authors： Chin AI,Depner TA,Daugirdas JT

更新日期：2017-05-01 00:00:00

abstract：:To prevent pyrogenic reactions during hemodialysis, it is recommended that bacteria and endotoxin in dialysate not exceed 100-200 colony forming units (CFU)/ml and 0.25-2 endotoxin units (EU)/ml, respectively. While these limits are adequate to prevent acute pyrogenic reactions, data are accumulating to suggest they m...

journal_title：Seminars in dialysis

authors： Ward RA

更新日期：2004-11-01 00:00:00

abstract：:Hemodialysis patients have multiple risk factors for small vessel cerebrovascular disease and cognitive dysfunction. Hemodialysis itself may cause clinically significant neurological injury through repetitive cerebral ischemia. However, supporting evidence to date consists of epidemiological associations, expert opini...

journal_title：Seminars in dialysis

authors： MacEwen C,Watkinson P,Tarassenko L,Pugh C

更新日期：2018-05-01 00:00:00

abstract：:Intradialytic hypotension (IDH) is a common complication of hemodialysis and is associated with numerous adverse outcomes including cardiovascular events, inadequate dialysis, loss of vascular access, and death. It is estimated that approximately 20%-30% of all dialysis sessions are affected by IDH. In seeking ways to...

journal_title：Seminars in dialysis

authors： Chang TI

更新日期：2017-11-01 00:00:00

abstract：:Cardiac resynchronization therapy with or without a defibrillator (CRT(D)) and implantable cardioverter defibrillator (ICD) may reduce the risk of arrhythmia or heart failure-specific mortality and improves the prognosis of patients with chronic kidney disease (CKD) or dialysis. The aim of this study was to perform a ...

journal_title：Seminars in dialysis

authors： Liu Y,Sun JY,Zhu YS,Li ZM,Li KL,Wang RX

更新日期：2020-12-09 00:00:00

abstract：:Elderly ESRD patients often lose functionality when they start dialysis, which may be due to a variety of clinical problems. We recently postulated that intensive (longer and/or more frequent) hemodialysis (HD) may be the ideal strategy to try to prevent these ESRD- and dialysis-related complications, including dialys...

journal_title：Seminars in dialysis

authors： Cornelis T,Kotanko P,Goffin E,van der Sande FM,Kooman JP,Chan CT

更新日期：2012-11-01 00:00:00

abstract：:Baclofen is an oral derivative of gamma-aminobutyric acid (GABA) used to treat muscular spasticity from disorders of the central nervous system. However, it is also being used for a variety of other conditions such as musculoskeletal pain, myoclonus, and alcohol withdrawal. The elimination of baclofen is heavily depen...

journal_title：Seminars in dialysis

authors： Roberts JK,Westphal S,Sparks MA

更新日期：2015-09-01 00:00:00

abstract：:This review aims to summarize the available evidence of the effectiveness of oral iron in patients receiving dialysis. Four small randomized controlled trials (105 evaluated patients) compared oral iron supplements with placebo or no treatment; hemoglobin and ferritin levels did not differ significantly between groups...

journal_title：Seminars in dialysis

authors： Hodson EM,Craig JC

更新日期：2014-01-01 00:00:00